Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Glenmark Pharmaceuticals Europe Limited, Laxmi House, 2B Draycott Avenue, Kenton, Middlesex, HA3 0BU, United Kingdom
Letrozole 2.5 mg Film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Dark yellow coloured, round shaped, slightly biconvex bevel edged, approx. 6mm in diameter film-coated tablets debossed with ‘5’ on one side and ‘H’ on the other side. |
Active substance: Letrozole.
Each film coated tablet contains 2.5 mg letrozole.
Excipients with known effect: Each tablet contains 85.0 mg of lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Letrozole |
Letrozole is a non-steroidal aromatase inhibitor. It inhibits the aromatase enzyme by competitively binding to the haem of the aromatase cytochrome P450, resulting in a reduction of oestrogen biosynthesis in all tissues where present. |
| List of Excipients |
|---|
|
Core tablets: Lactose monohydrate Tablet coating: Hypromellose (464) |
Aluminium/Aluminium blister packs and PVC/PE/PVDC/aluminium blister packs.
Pack sizes: 10, 14, 28, 30, 90, 98 or 100 film-coated tablets.
Not all pack sizes may be marketed.
Glenmark Pharmaceuticals Europe Limited, Laxmi House, 2B Draycott Avenue, Kenton, Middlesex, HA3 0BU, United Kingdom
PL 25258/0198
18/02/2016
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
